Clinical Trial Update: Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated the safety and reactogenicity of GlaxoSmithKline's Hib (Haemophilus influenzae type b) vaccine when administered with or w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease

Drugs mentioned

• Hib vaccine (Haemophilus influenzae type b vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b Disease | Phase 4 | Status: COMPLETED